Wealth Effects »

Monte Rosa Therapeutics shares owned by Wealth Effects

Quarter-by-quarter ownership of Monte Rosa Therapeutics (GLUE) shares owned by Wealth Effects from 13F filings

Historical chart of Wealth Effects investment in Monte Rosa Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Monte Rosa Therapeutics held by Wealth Effects consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Monte Rosa Therapeutics by Wealth Effects

Quarter filed Position value Share count Share price at filing
2025-09-30 $75k 10k 7.41

More positions owned by Wealth Effects

Avadel Pharmaceuticals Com Shs (AVDL)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Amazon (AMZN)
JPMorgan Chase & Co. (JPM)
Vanguard Index Fds Total Stk Mkt (VTI)
Microsoft Corporation (MSFT)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Arrowhead Pharmaceuticals (ARWR)
Broadcom (AVGO)
Blackstone Group Inc Com Cl A (BX)
International Business Machines (IBM)
United Rentals (URI)
Tesla Motors (TSLA)

View all positions for Wealth Effects

Top funds holding Monte Rosa Therapeutics

NEA Management Company
BVF
Versant Venture Management
Baker Bros. Advisors
BlackRock
Suvretta Capital Management
Vanguard Group
FMR
Aisling Capital Management
Alphabet
Geode Capital Management
Marshall Wace
State Street Corporation
Vestal Point Capital
Northern Trust

View all funds holding Monte Rosa Therapeutics